TILDRAKIZUMAB-ASMN

TILDRAKIZUMAB-ASMN was reported 2410 times

TILDRAKIZUMAB-ASMN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ELECTROPHORESIS ABNORMAL 1 0.0417
1 MUMPS ANTIBODY TEST NEGATIVE 1 0.0370
2 SELF-MEDICATION 92 0.0224
3 ADENOCARCINOMA OF APPENDIX 1 0.0149
4 TREATMENT DELAYED 24 0.0139
5 NAIL BED TENDERNESS 1 0.0088
6 WRONG DOSAGE FORMULATION 1 0.0081
7 BED BUG INFESTATION 1 0.0079
8 PENILE CANCER 1 0.0076
9 INTENTIONAL DOSE OMISSION 215 0.0075
10 TESTICULAR CYST 1 0.0060
11 WEST NILE VIRAL INFECTION 4 0.0053
12 MALIGNANT MELANOMA STAGE 0 1 0.0048
13 URINE SODIUM INCREASED 1 0.0047
14 ALANINE AMINOTRANSFERASE 1 0.0045
15 SQUAMOUS CELL CARCINOMA OF HEAD AND NECK 1 0.0043
16 TONGUE NEOPLASM 1 0.0042
17 ASPARTATE AMINOTRANSFERASE 1 0.0041
18 PALMOPLANTAR PUSTULOSIS 2 0.0038
19 GUTTATE PSORIASIS 3 0.0037
20 CATHETER SITE CELLULITIS 1 0.0034
21 HAIR INJURY 1 0.0034
22 CATHETER SITE BRUISE 1 0.0030
23 MEDIAL TIBIAL STRESS SYNDROME 1 0.0029
24 IDIOPATHIC INTERSTITIAL PNEUMONIA 1 0.0028
25 PRODUCT ADMINISTERED BY WRONG PERSON 1 0.0026
26 INVASIVE BREAST CARCINOMA 1 0.0024
27 NAIL BED DISORDER 1 0.0023
28 SKIN INDENTATION 1 0.0021
29 PATIENT UNCOOPERATIVE 1 0.0021
30 WRONG SCHEDULE 2 0.0021
31 BLOOD URIC ACID DECREASED 1 0.0021
32 TINEA CRURIS 1 0.0020
33 INAPPROPRIATE SCHEDULE OF PRODUCT DISCONTINUATION 1 0.0019
34 BODY FAT DISORDER 1 0.0018
35 PRODUCT CLOSURE ISSUE 1 0.0018
36 BODY TINEA 1 0.0018
37 REBOUND PSORIASIS 1 0.0017
38 DEVICE MAINTENANCE ISSUE 1 0.0017
39 URETHRAL PAIN 1 0.0017
40 INFUSION RELATED HYPERSENSITIVITY REACTION 1 0.0017
41 PRODUCT DOSE OMISSION ISSUE 489 0.0017
42 THERAPY CESSATION 85 0.0017
43 HYPERGAMMAGLOBULINAEMIA BENIGN MONOCLONAL 1 0.0016
44 NAIL PSORIASIS 1 0.0016
45 CUTANEOUS T-CELL LYMPHOMA 2 0.0016
46 SOCIAL ANXIETY DISORDER 1 0.0015
47 SINGLE FUNCTIONAL KIDNEY 1 0.0015
48 LICHEN SCLEROSUS 1 0.0015
49 SUTURE RUPTURE 1 0.0014
50 DERMATITIS EXFOLIATIVE GENERALISED 5 0.0014
51 PRODUCT LEAKAGE 8 0.0014
52 FACIAL DISCOMFORT 1 0.0014
53 PRODUCT ADMINISTRATION INTERRUPTED 11 0.0014
54 GRANULOMA ANNULARE 1 0.0014
55 IMPETIGO 2 0.0013
56 EXPOSURE TO COMMUNICABLE DISEASE 1 0.0013
57 ALLERGIC COUGH 1 0.0013
58 CRITICAL ILLNESS 1 0.0013
59 LABORATORY TEST INTERFERENCE 1 0.0013
60 MYCOBACTERIUM TUBERCULOSIS COMPLEX TEST POSITIVE 3 0.0013
61 PRODUCT ADMINISTRATION ERROR 25 0.0012
62 BLOOD TRIGLYCERIDES ABNORMAL 1 0.0011
63 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 37 0.0011
64 ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION 1 0.0011
65 DRUG DISPENSED TO WRONG PATIENT 1 0.0010
66 SKIN TEXTURE ABNORMAL 1 0.0010
67 FALSE POSITIVE INVESTIGATION RESULT 1 0.0010
68 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
69 PRODUCT STORAGE ERROR 84 0.0010
70 INJECTION SITE HYPERSENSITIVITY 3 0.0010
71 URETEROLITHIASIS 1 0.0010
72 SLEEP DEFICIT 2 0.0009
73 PRODUCT NAME CONFUSION 1 0.0009
74 ACARODERMATITIS 1 0.0009
75 BENIGN NEOPLASM 1 0.0009
76 LIGAMENT INJURY 1 0.0009
77 FULL BLOOD COUNT INCREASED 1 0.0008
78 PSORIASIS 109 0.0008
79 DISEASE RECURRENCE 39 0.0008
80 MALIGNANT MELANOMA IN SITU 1 0.0008
81 RECTAL TENESMUS 1 0.0008
82 HYPERAESTHESIA TEETH 1 0.0008
83 WEIGHT BEARING DIFFICULTY 2 0.0007
84 APPENDIX DISORDER 1 0.0007
85 BLOOD ELECTROLYTES DECREASED 1 0.0007
86 INJECTION SITE HYPOAESTHESIA 1 0.0007
87 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
88 MARASMUS 1 0.0007
89 TALIPES 2 0.0006
90 PULMONARY FUNCTION TEST ABNORMAL 1 0.0006
91 URINE KETONE BODY PRESENT 1 0.0006
92 TINEA PEDIS 1 0.0006
93 COLON CANCER METASTATIC 1 0.0006
94 SEBORRHOEIC DERMATITIS 1 0.0006
95 THERAPY INTERRUPTED 43 0.0006
96 TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED 1 0.0006
97 PUSTULAR PSORIASIS 2 0.0006
98 MILIARIA 1 0.0006
99 ACUTE SINUSITIS 1 0.0006
100 SYRINGE ISSUE 10 0.0006
101 POOR QUALITY PRODUCT ADMINISTERED 6 0.0006
102 VOCAL CORD PARALYSIS 1 0.0006
103 THERAPEUTIC RESPONSE DECREASED 33 0.0005
104 HYPERKERATOSIS 3 0.0005
105 DIFFUSE ALOPECIA 1 0.0005
106 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
107 SINUS HEADACHE 3 0.0005
108 OESOPHAGEAL CANDIDIASIS 2 0.0005
109 RECURRENT CANCER 2 0.0005
110 PIGMENTATION DISORDER 3 0.0005
111 RENAL MASS 1 0.0005
112 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 86 0.0005
113 DEVICE CONNECTION ISSUE 1 0.0005
114 EYE CONTUSION 1 0.0005
115 RENAL NEOPLASM 1 0.0005
116 MIDDLE EAR EFFUSION 1 0.0005
117 INFECTIOUS MONONUCLEOSIS 1 0.0004
118 VASCULAR DEVICE INFECTION 2 0.0004
119 LICHENOID KERATOSIS 1 0.0004
120 READING DISORDER 1 0.0004
121 UTERINE DISORDER 1 0.0004
122 PUSTULE 1 0.0004
123 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 1 0.0004
124 BREATH ODOUR 1 0.0004
125 HAEMATOLOGICAL INFECTION 1 0.0004
126 ACUTE PSYCHOSIS 1 0.0004
127 CATHETER SITE HAEMORRHAGE 1 0.0004
128 CONDITION AGGRAVATED 121 0.0004
129 URINARY TRACT INFECTION BACTERIAL 1 0.0004
130 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
131 APPENDICITIS PERFORATED 1 0.0004
132 CATHETER SITE PAIN 1 0.0004
133 EXFOLIATIVE RASH 1 0.0004
134 IMMUNE SYSTEM DISORDER 5 0.0004
135 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
136 BLOOD SODIUM INCREASED 1 0.0004
137 ORAL FUNGAL INFECTION 1 0.0004
138 FAECALOMA 2 0.0004
139 SKIN HYPERTROPHY 1 0.0004
140 NECK MASS 1 0.0004
141 HAEMATOLOGICAL MALIGNANCY 1 0.0004
142 EYELID MARGIN CRUSTING 1 0.0003
143 PSORIATIC ARTHROPATHY 14 0.0003
144 ABORTION 1 0.0003
145 TOOTH DISCOLOURATION 1 0.0003
146 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
147 HIDRADENITIS 3 0.0003
148 KERATITIS 1 0.0003
149 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
150 PRODUCT DISTRIBUTION ISSUE 3 0.0003
151 THERAPY PARTIAL RESPONDER 5 0.0003
152 INFUSION SITE PRURITUS 1 0.0003
153 LOOSE TOOTH 1 0.0003
154 LIVER ABSCESS 1 0.0003
155 HERPES SIMPLEX 2 0.0003
156 SKIN FISSURES 6 0.0003
157 HEPATIC NEOPLASM 1 0.0003
158 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
159 SUSPECTED COVID-19 1 0.0003
160 CORONAVIRUS INFECTION 2 0.0003
161 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 1 0.0003
162 SKIN INJURY 1 0.0003
163 LYME DISEASE 1 0.0003
164 HEPATIC CYST 1 0.0003
165 EXPOSURE DURING PREGNANCY 18 0.0003
166 FEAR OF INJECTION 2 0.0003
167 SKIN WEEPING 1 0.0003
168 DEVICE PLACEMENT ISSUE 1 0.0003
169 APPARENT DEATH 1 0.0003
170 PARADOXICAL DRUG REACTION 1 0.0003
171 ALCOHOL USE 1 0.0003
172 SKIN HAEMORRHAGE 4 0.0003
173 PRODUCT AVAILABILITY ISSUE 6 0.0003
174 DERMATITIS CONTACT 3 0.0003
175 FOOD ALLERGY 2 0.0003
176 THERAPEUTIC PRODUCT INEFFECTIVE 1 0.0003
177 PANIC DISORDER 1 0.0003
178 VIRAL LOAD INCREASED 1 0.0003
179 NAIL DISCOLOURATION 1 0.0003
180 ACCIDENT 3 0.0003
181 ORGAN FAILURE 1 0.0002
182 PRODUCT PHYSICAL ISSUE 5 0.0002
183 FUNGAL SKIN INFECTION 1 0.0002
184 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
185 THERAPY NON-RESPONDER 11 0.0002
186 INJECTION SITE URTICARIA 6 0.0002
187 APPLICATION SITE EXFOLIATION 1 0.0002
188 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
189 NEEDLE ISSUE 7 0.0002
190 SUICIDAL BEHAVIOUR 1 0.0002
191 DRUG INEFFECTIVE 313 0.0002
192 HEPATIC PAIN 1 0.0002
193 PULMONARY TUBERCULOSIS 1 0.0002
194 SCAR 4 0.0002
195 ALCOHOLISM 1 0.0002
196 PRURITUS 89 0.0002
197 HORDEOLUM 1 0.0002
198 DEVICE DEFECTIVE 4 0.0002
199 BONE CANCER 1 0.0002
200 INTENTIONAL PRODUCT USE ISSUE 20 0.0002
201 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
202 DRUG ERUPTION 4 0.0002
203 THERAPEUTIC RESPONSE UNEXPECTED 10 0.0002
204 THERAPEUTIC PRODUCT EFFECT DELAYED 1 0.0002
205 IMMUNE THROMBOCYTOPENIA 1 0.0002
206 RETINAL DETACHMENT 2 0.0002
207 TREATMENT FAILURE 18 0.0002
208 ARTHRITIS INFECTIVE 1 0.0002
209 YELLOW SKIN 1 0.0002
210 SKIN TIGHTNESS 1 0.0002
211 SQUAMOUS CELL CARCINOMA 2 0.0002
212 PRODUCT PACKAGING ISSUE 2 0.0002
213 VIRAL UPPER RESPIRATORY TRACT INFECTION 1 0.0002
214 GUILLAIN-BARRE SYNDROME 1 0.0002
215 INCORRECT DOSAGE ADMINISTERED 1 0.0002
216 INFLAMMATORY BOWEL DISEASE 2 0.0002
217 BREATH SOUNDS ABNORMAL 1 0.0002
218 SINUS DISORDER 4 0.0002
219 COLON CANCER 3 0.0002
220 IMMUNODEFICIENCY 3 0.0002
221 CORONARY ARTERIAL STENT INSERTION 1 0.0002
222 TOE AMPUTATION 1 0.0002
223 FEMORAL NECK FRACTURE 1 0.0002
224 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
225 DEATH 167 0.0002
226 RESPIRATORY TRACT INFECTION 5 0.0002
227 PETECHIAE 2 0.0002
228 APLASTIC ANAEMIA 1 0.0002
229 ANAL FISTULA 1 0.0002
230 ANAL FISSURE 1 0.0002
231 OVERWEIGHT 1 0.0002
232 VIROLOGIC FAILURE 1 0.0002
233 RASH 81 0.0002
234 PHARYNGITIS STREPTOCOCCAL 2 0.0002
235 FOOT DEFORMITY 2 0.0002
236 DIVERTICULITIS 5 0.0002
237 NEOPLASM MALIGNANT 12 0.0002
238 CELLULITIS 9 0.0002
239 NEOPLASM 2 0.0002
240 SKIN ATROPHY 1 0.0002
241 METABOLIC DISORDER 1 0.0002
242 CHOLECYSTITIS 2 0.0002
243 ODYNOPHAGIA 1 0.0002
244 INJECTION SITE VESICLES 1 0.0002
245 INGUINAL HERNIA 1 0.0002
246 MENISCUS INJURY 1 0.0002
247 SWELLING OF EYELID 1 0.0002
248 ANGINA UNSTABLE 1 0.0002
249 NODULE 2 0.0002
250 ORAL CANDIDIASIS 2 0.0002
251 PULMONARY CONGESTION 2 0.0002
252 WALKING AID USER 1 0.0002
253 SKIN MASS 1 0.0001
254 TREATMENT NONCOMPLIANCE 8 0.0001
255 ONYCHOCLASIS 1 0.0001
256 AUTOIMMUNE HEPATITIS 1 0.0001
257 SKIN EXFOLIATION 12 0.0001
258 PAPULE 1 0.0001
259 SEASONAL ALLERGY 2 0.0001
260 HAND FRACTURE 1 0.0001
261 HERPES ZOSTER 8 0.0001
262 PRODUCT DOSE OMISSION 9 0.0001
263 RASH PUSTULAR 1 0.0001
264 PAROSMIA 1 0.0001
265 INJECTION SITE RASH 4 0.0001
266 ANKLE FRACTURE 2 0.0001
267 BURNING SENSATION 9 0.0001
268 BASAL CELL CARCINOMA 2 0.0001
269 MULTIPLE ALLERGIES 1 0.0001
270 AFFECTIVE DISORDER 1 0.0001
271 ILLNESS 13 0.0001
272 NASAL DISCOMFORT 1 0.0001
273 SCIATICA 2 0.0001
274 UTERINE CANCER 1 0.0001
275 MYASTHENIA GRAVIS 1 0.0001
276 MUSCLE DISORDER 1 0.0001
277 BACK DISORDER 2 0.0001
278 MENSTRUAL DISORDER 1 0.0001
279 COVID-19 21 0.0001
280 BLOOD UREA INCREASED 2 0.0001
281 SENSATION OF FOREIGN BODY 1 0.0001
282 URINARY TRACT INFECTION 20 0.0001
283 MUSCULOSKELETAL DISCOMFORT 2 0.0001
284 PYELONEPHRITIS 1 0.0001
285 SKIN SWELLING 1 0.0001
286 ARTHRITIS 9 0.0001
287 NAIL DISORDER 1 0.0001
288 PURPURA 1 0.0001
289 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 8 0.0001
290 GALLBLADDER DISORDER 2 0.0001
291 FACIAL PAIN 1 0.0001
292 PAIN OF SKIN 3 0.0001
293 ANAL INCONTINENCE 1 0.0001
294 INFECTION 16 0.0001
295 OFF LABEL USE 96 0.0001
296 SKIN LESION 3 0.0001
297 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
298 HEPATIC STEATOSIS 2 0.0001
299 NEPHROPATHY 1 0.0001
300 LEUKAEMIA 1 0.0001
301 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
302 BLOOD URINE PRESENT 2 0.0001
303 RED BLOOD CELL COUNT DECREASED 3 0.0001
304 LOWER LIMB FRACTURE 2 0.0001
305 HYPERCHOLESTEROLAEMIA 1 0.0001
306 EAR PAIN 2 0.0001
307 ORAL HERPES 2 0.0001
308 PHARYNGEAL SWELLING 1 0.0001
309 VITREOUS FLOATERS 1 0.0001
310 THERAPY CHANGE 1 0.0001
311 LIGAMENT SPRAIN 1 0.0001
312 GASTROINTESTINAL DISORDER 9 0.0001
313 RESPIRATORY DISORDER 3 0.0001
314 MYALGIA 17 0.0001
315 BRAIN INJURY 1 0.0001
316 POOR QUALITY DEVICE USED 1 0.0001
317 EMPHYSEMA 1 0.0001
318 TASTE DISORDER 2 0.0001
319 TOOTH ABSCESS 1 0.0001
320 LUNG NEOPLASM MALIGNANT 4 0.0001
321 VENTRICULAR EXTRASYSTOLES 1 0.0001
322 SCRATCH 1 0.0001
323 IRRITABLE BOWEL SYNDROME 2 0.0001
324 LIVER FUNCTION TEST INCREASED 2 0.0001
325 SKIN CANCER 2 0.0001
326 BIPOLAR DISORDER 1 0.0001
327 SKIN LACERATION 1 0.0001
328 PRODUCT DISPENSING ERROR 2 0.0001
329 ALOPECIA 18 0.0001
330 STAPHYLOCOCCAL INFECTION 3 0.0001
331 EXPIRED PRODUCT ADMINISTERED 3 0.0001
332 FUNGAL INFECTION 3 0.0001
333 NERVE INJURY 1 0.0001
334 DEVICE ISSUE 8 0.0001
335 SKIN INFECTION 1 0.0001
336 CHROMATURIA 2 0.0001
337 EYE INFECTION 1 0.0001
338 SINUSITIS 9 0.0001
339 SCAB 1 0.0001
340 SKIN IRRITATION 4 0.0001
341 GASTRIC HAEMORRHAGE 1 0.0001
342 NASOPHARYNGITIS 16 0.0001
343 OROPHARYNGEAL PAIN 8 0.0001
344 VASCULITIS 1 0.0001
345 BREAST CANCER 8 0.0001
346 BLOOD CHOLESTEROL INCREASED 4 0.0001
347 DEVICE MALFUNCTION 6 0.0001
348 NASAL CONGESTION 5 0.0001
349 ARTHRALGIA 35 0.0001
350 COMA 4 0.0001
351 PRODUCT PRESCRIBING ERROR 2 0.0001
352 WRIST FRACTURE 1 0.0001
353 THYROID CANCER 1 0.0001
354 TENDON RUPTURE 1 0.0001
355 PHARYNGITIS 1 0.0001
356 TOOTH EXTRACTION 1 0.0001
357 PNEUMONIA ASPIRATION 2 0.0001
358 SECRETION DISCHARGE 1 0.0001
359 DERMATITIS ALLERGIC 1 0.0001
360 MUSCLE ATROPHY 1 0.0001
361 RHINORRHOEA 5 0.0001
362 DISEASE PROGRESSION 9 0.0001
363 ADVERSE REACTION 1 0.0001
364 EAR INFECTION 2 0.0001
365 DRY SKIN 10 0.0001
366 MALIGNANT MELANOMA 1 0.0001
367 SINUS CONGESTION 1 0.0001
368 THROAT TIGHTNESS 2 0.0001
369 UVEITIS 1 0.0001
370 PRODUCT QUALITY ISSUE 10 0.0001
371 PALLOR 2 0.0001
372 IMPAIRED GASTRIC EMPTYING 1 0.0001
373 HEPATIC ENZYME INCREASED 5 0.0001
374 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
375 DIARRHOEA 47 0.0001
376 HUNGER 1 0.0001
377 ROAD TRAFFIC ACCIDENT 3 0.0001
378 APHONIA 1 0.0001
379 EYE PAIN 4 0.0001
380 PAIN IN JAW 2 0.0001
381 HYPERSENSITIVITY 13 0.0001
382 PARALYSIS 1 0.0001
383 PARAESTHESIA ORAL 1 0.0001
384 LABORATORY TEST ABNORMAL 2 0.0001
385 THROAT IRRITATION 3 0.0001
386 HOT FLUSH 5 0.0001
387 HYPOAESTHESIA ORAL 1 0.0001
388 HEPATIC FAILURE 2 0.0001
389 DISCOMFORT 4 0.0001
390 SKIN DISCOLOURATION 3 0.0001
391 PERIPHERAL SWELLING 10 0.0001
392 THYROID DISORDER 1 0.0001
393 LYMPHOMA 1 0.0001
394 MUSCULOSKELETAL CHEST PAIN 1 0.0001
395 TENDONITIS 1 0.0001
396 SWELLING 6 0.0001
397 BRAIN FOG 1 0.0001
398 PRODUCT USE COMPLAINT 1 0.0001
399 CYSTITIS 2 0.0001
400 ABSCESS 1 0.0001
401 NIGHT SWEATS 2 0.0001
402 ATRIAL FIBRILLATION 6 0.0001
403 BLOOD POTASSIUM INCREASED 1 0.0001
404 LUNG DISORDER 3 0.0001
405 INFLUENZA LIKE ILLNESS 5 0.0001
406 VENTRICULAR TACHYCARDIA 1 0.0001
407 PHOTOSENSITIVITY REACTION 1 0.0001
408 CYTOMEGALOVIRUS INFECTION 1 0.0001
409 VIRAL INFECTION 2 0.0001
410 LIP SWELLING 2 0.0001
411 INJECTION SITE PRURITUS 4 0.0001
412 ABDOMINAL DISCOMFORT 10 0.0001
413 PERICARDITIS 1 0.0001
414 CANDIDA INFECTION 1 0.0001
415 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 1 0.0001
416 INFLAMMATION 3 0.0001
417 NIGHTMARE 2 0.0001
418 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
419 ECZEMA 3 0.0001
420 RASH MACULAR 2 0.0001
421 DEVICE USE ISSUE 1 0.0001
422 DERMATITIS ATOPIC 3 0.0001
423 COLD SWEAT 1 0.0001
424 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
425 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
426 ISCHAEMIC STROKE 1 0.0001
427 THIRST 1 0.0001
428 GOUT 1 0.0001
429 PNEUMONIA 18 0.0001
430 GASTROENTERITIS VIRAL 1 0.0001
431 RASH PRURITIC 3 0.0001
432 LEUKOCYTOSIS 1 0.0001
433 BONE DISORDER 1 0.0001
434 ANAPHYLACTIC REACTION 3 0.0001
435 BLOOD GLUCOSE ABNORMAL 1 0.0001
436 INJECTION SITE MASS 2 0.0001
437 BRONCHITIS 4 0.0001
438 CONJUNCTIVITIS 1 0.0001
439 EYE SWELLING 2 0.0001
440 URTICARIA 9 0.0001
441 PAIN 33 0.0001
442 BACTERIAL INFECTION 1 0.0001
443 HEPATIC FUNCTION ABNORMAL 2 0.0001
444 EPISTAXIS 4 0.0001
445 CARDIAC DISORDER 5 0.0001
446 BLISTER 3 0.0001
447 HYPOCALCAEMIA 1 0.0001
448 FRACTURE 1 0.0001
449 FOOT FRACTURE 1 0.0001
450 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
451 HERNIA 1 0.0001
452 PLASMA CELL MYELOMA 2 0.0001
453 BLADDER CANCER 3 0.0001
454 WEIGHT DECREASED 14 0.0001
455 INJECTION SITE HAEMORRHAGE 4 0.0001
456 COUGH 14 0.0000
457 SPINAL FRACTURE 1 0.0000
458 PROSTATE CANCER 4 0.0000
459 INJURY ASSOCIATED WITH DEVICE 1 0.0000
460 MUSCLE SPASMS 9 0.0000
461 BODY TEMPERATURE INCREASED 1 0.0000
462 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
463 PRODUCT PREPARATION ERROR 1 0.0000
464 POLLAKIURIA 2 0.0000
465 PRODUCT USE ISSUE 9 0.0000
466 EATING DISORDER 1 0.0000
467 RETCHING 1 0.0000
468 LOSS OF CONSCIOUSNESS 6 0.0000
469 IMPAIRED WORK ABILITY 1 0.0000
470 AMNESIA 3 0.0000
471 BLOOD CREATININE INCREASED 3 0.0000
472 INTERVERTEBRAL DISC PROTRUSION 1 0.0000
473 APPLICATION SITE PAIN 1 0.0000
474 ANGIOEDEMA 2 0.0000
475 GAMMA-GLUTAMYLTRANSFERASE INCREASED 1 0.0000
476 INFLUENZA 5 0.0000
477 ORAL PAIN 1 0.0000
478 PARAESTHESIA 7 0.0000
479 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
480 INJECTION SITE REACTION 3 0.0000
481 MUSCLE TWITCHING 1 0.0000
482 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 2 0.0000
483 CHILLS 5 0.0000
484 DIZZINESS 21 0.0000
485 NEUROPATHY PERIPHERAL 4 0.0000
486 PRODUCTIVE COUGH 2 0.0000
487 SKIN BURNING SENSATION 3 0.0000
488 RASH ERYTHEMATOUS 2 0.0000
489 BLOOD PRESSURE FLUCTUATION 1 0.0000
490 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 2 0.0000
491 HEPATIC CANCER 1 0.0000
492 JOINT SWELLING 5 0.0000
493 LOCALISED INFECTION 1 0.0000
494 CEREBROVASCULAR ACCIDENT 7 0.0000
495 INTERSTITIAL LUNG DISEASE 2 0.0000
496 PRESYNCOPE 1 0.0000
497 UNDERDOSE 3 0.0000
498 CEREBRAL INFARCTION 1 0.0000
499 DYSPEPSIA 4 0.0000
500 DYSPNOEA 23 0.0000
501 ACNE 3 0.0000
502 GASTRIC CANCER 1 0.0000
503 INJECTION SITE SWELLING 3 0.0000
504 HEPATITIS 1 0.0000
505 CHEST DISCOMFORT 4 0.0000
506 ERECTILE DYSFUNCTION 1 0.0000
507 DRUG RESISTANCE 1 0.0000
508 ERYTHEMA 8 0.0000
509 MALAISE 17 0.0000
510 SKIN ULCER 1 0.0000
511 RASH GENERALISED 1 0.0000
512 ABDOMINAL DISTENSION 4 0.0000
513 HAEMORRHAGE 4 0.0000
514 MUCOSAL INFLAMMATION 1 0.0000
515 JOINT STIFFNESS 1 0.0000
516 PANCREATITIS 2 0.0000
517 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
518 PYREXIA 13 0.0000
519 PLATELET COUNT DECREASED 4 0.0000
520 CARDIAC FAILURE 3 0.0000
521 THROMBOSIS 3 0.0000
522 JAUNDICE 1 0.0000
523 CONSTIPATION 8 0.0000
524 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0000
525 CARDIAC ARREST 3 0.0000
526 ABNORMAL DREAMS 1 0.0000
527 ARTHROPATHY 2 0.0000
528 DEMENTIA 1 0.0000
529 WOUND 1 0.0000
530 HYPONATRAEMIA 2 0.0000
531 FLATULENCE 2 0.0000
532 HYPERSOMNIA 1 0.0000
533 LETHARGY 2 0.0000
534 DYSSTASIA 1 0.0000
535 DYSPHONIA 2 0.0000
536 PAIN IN EXTREMITY 10 0.0000
537 PSYCHOTIC DISORDER 1 0.0000
538 URINARY INCONTINENCE 1 0.0000
539 CATARACT 2 0.0000
540 HYPOAESTHESIA 5 0.0000
541 BLOOD POTASSIUM DECREASED 1 0.0000
542 LACRIMATION INCREASED 1 0.0000
543 SUICIDAL IDEATION 3 0.0000
544 CHEST PAIN 6 0.0000
545 LIMB DISCOMFORT 1 0.0000
546 INJECTION SITE ERYTHEMA 4 0.0000
547 FATIGUE 25 0.0000
548 MIGRAINE 3 0.0000
549 CONTUSION 3 0.0000
550 DRUG INTOLERANCE 3 0.0000
551 CHOLELITHIASIS 1 0.0000
552 THERAPEUTIC RESPONSE SHORTENED 1 0.0000
553 SKIN DISORDER 1 0.0000
554 URINARY RETENTION 1 0.0000
555 GAIT INABILITY 1 0.0000
556 EYE PRURITUS 1 0.0000
557 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 6 0.0000
558 FLUSHING 3 0.0000
559 HAEMATURIA 1 0.0000
560 ABDOMINAL PAIN UPPER 6 0.0000
561 VISION BLURRED 4 0.0000
562 DEVICE USE ERROR 1 0.0000
563 MYOCARDIAL INFARCTION 5 0.0000
564 HYPERKALAEMIA 1 0.0000
565 LYMPHADENOPATHY 1 0.0000
566 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
567 PRODUCT ADHESION ISSUE 1 0.0000
568 PANIC ATTACK 1 0.0000
569 RESPIRATORY FAILURE 2 0.0000
570 DYSURIA 1 0.0000
571 THROMBOCYTOPENIA 3 0.0000
572 DYSARTHRIA 1 0.0000
573 ASTHMA 3 0.0000
574 INTESTINAL OBSTRUCTION 1 0.0000
575 COLITIS 1 0.0000
576 INCORRECT DOSE ADMINISTERED 6 0.0000
577 DIABETES MELLITUS 2 0.0000
578 SEIZURE 3 0.0000
579 BACK PAIN 6 0.0000
580 EXTRA DOSE ADMINISTERED 1 0.0000
581 DRY MOUTH 2 0.0000
582 OEDEMA PERIPHERAL 3 0.0000
583 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
584 BLINDNESS 1 0.0000
585 OSTEOPOROSIS 1 0.0000
586 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
587 CARDIO-RESPIRATORY ARREST 1 0.0000
588 BALANCE DISORDER 2 0.0000
589 MUSCULOSKELETAL STIFFNESS 2 0.0000
590 RENAL FAILURE 3 0.0000
591 HEADACHE 14 0.0000
592 WEIGHT INCREASED 5 0.0000
593 NO ADVERSE EVENT 4 0.0000
594 NEPHROLITHIASIS 1 0.0000
595 RENAL DISORDER 1 0.0000
596 COGNITIVE DISORDER 1 0.0000
597 OCULAR HYPERAEMIA 1 0.0000
598 FALL 7 0.0000
599 RENAL CANCER 1 0.0000
600 NAUSEA 16 0.0000
601 DRY EYE 1 0.0000
602 LEUKOPENIA 1 0.0000
603 SYNCOPE 2 0.0000
604 AGGRESSION 1 0.0000
605 FLUID RETENTION 1 0.0000
606 HAEMOGLOBIN DECREASED 2 0.0000
607 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
608 DEPRESSED MOOD 1 0.0000
609 HYPERTENSION 4 0.0000
610 BRADYCARDIA 1 0.0000
611 ASTHENIA 7 0.0000
612 OEDEMA 1 0.0000
613 HAEMATOCHEZIA 1 0.0000
614 MEDICATION ERROR 1 0.0000
615 SEPSIS 2 0.0000
616 NECK PAIN 1 0.0000
617 EYE IRRITATION 1 0.0000
618 DECREASED APPETITE 4 0.0000
619 ABDOMINAL PAIN 4 0.0000
620 PALPITATIONS 2 0.0000
621 BONE PAIN 1 0.0000
622 WHEEZING 1 0.0000
623 FEELING ABNORMAL 4 0.0000
624 ILL-DEFINED DISORDER 1 0.0000
625 PLEURAL EFFUSION 1 0.0000
626 VERTIGO 1 0.0000
627 FEELING HOT 1 0.0000
628 INJECTION SITE PAIN 5 0.0000
629 VISUAL IMPAIRMENT 2 0.0000
630 ANAEMIA 3 0.0000
631 GAIT DISTURBANCE 3 0.0000
632 HYPERHIDROSIS 2 0.0000
633 SWELLING FACE 1 0.0000
634 DEVICE DIFFICULT TO USE 1 0.0000
635 BLOOD PRESSURE DECREASED 1 0.0000
636 INSOMNIA 4 0.0000
637 DEHYDRATION 2 0.0000
638 ANXIETY 4 0.0000
639 OVERDOSE 3 0.0000
640 AGITATION 1 0.0000
641 DYSGEUSIA 1 0.0000
642 HALLUCINATION 1 0.0000
643 DEPRESSION 3 0.0000
644 BLOOD PRESSURE INCREASED 2 0.0000
645 HOSPITALISATION 2 0.0000
646 VOMITING 6 0.0000
647 INJECTION SITE BRUISING 1 0.0000
648 CARDIAC FAILURE CONGESTIVE 1 0.0000
649 GASTROOESOPHAGEAL REFLUX DISEASE 1 0.0000
650 TREMOR 2 0.0000
651 RENAL IMPAIRMENT 1 0.0000
652 ADVERSE DRUG REACTION 1 0.0000
653 BLOOD GLUCOSE INCREASED 2 0.0000
654 DYSPHAGIA 1 0.0000
655 PULMONARY EMBOLISM 1 0.0000
656 HEART RATE INCREASED 1 0.0000
657 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
658 MUSCULAR WEAKNESS 1 0.0000
659 NEUTROPENIA 1 0.0000
660 ACUTE KIDNEY INJURY 1 0.0000
661 SOMNOLENCE 1 0.0000
662 PRODUCT USE IN UNAPPROVED INDICATION 1 0.0000